Browsing publications by Dr Mark Hudson

Newcastle AuthorsTitleYearFull text
Dr Stuart McPherson
Dr Jessica Dyson
Dr Mark Hudson
Editorial: improving in-hospital management of decompensated cirrhosis by a ‘care bundle’ – hope, frustration and lessons to learn. Authors’ reply2017
Dr Holly Standing
Dr Helen Jarvis
Dr James Orr
Professor Cath Exley
Dr Mark Hudson
et al.
How can primary care enhance end-of-life care for liver disease? Qualitative study of general practitioners' perceptions and experiences2017
Dr Mark Hudson
Should we screen for cirrhosis?2017
Dr Mark Hudson
The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: A retrospective observational study (IMPRESS)2017
Dr James Orr
Daniel Stow
Professor Fiona Matthews
Professor Barbara Hanratty
Professor David Jones
et al.
Eleven-year mortality and referral practices associated with abnormal alanine aminotransferase (ALT) results2016
Dr Louise Coats
Dr David Crossland
Dr Mark Hudson
Dr John O'Sullivan
Fontan conversion is a dated approach to the failing Fontan2016
Dr David Crossland
Dr Mark Hudson
Fontan-associated liver disease: Implications for heart transplantation2016
Dr Jessica Dyson
Dr Chris Lamb
Dr Steven Masson
Dr Mark Hudson
Dr Christian Dipper
et al.
Implementation of a “care bundle” improves the management of patients admitted to hospital with decompensated cirrhosis2016
Dr James Orr
Dr Mark Hudson
Natural History of Patients Taking Rifaximin-α for Recurrent Hepatic Encephalopathy and Risk of Future Overt Episodes and Mortality: A Post-hoc Analysis of Clinical Trials Data2016
Dr Jessica Dyson
Dr Mark Hudson
New metrics for the Lancet Standing Commission on Liver Disease in the UK2016
123456789101112